National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

ProstaScint (PROS-tuh-sint)

 A substance used to detect prostate cancer. It contains a monoclonal antibody that binds to prostate cells, linked to a substance that can bind radioisotopes. ProstaScint is combined with indium 111 and injected into the body. A gamma camera (a special camera that detects radioactivity) is used to find prostate cancer cells in the body. ProstaScint is a type of immunoconjugate. Also called capromab pendetide.



Previous Definitions:prospective cohort study, Prost 30, prostaglandin, prostaglandin E1, prostaglandin-endoperoxide synthase 2
Next Definitions:ProstaScint scan, prostate, prostate cancer, prostate-specific antigen, prostate-specific antigen test

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov